As advocacy efforts bolster the need for patient-focused drug development, amidst regulatory encouragement, the value of listening to patients is being realised in a more actionable manner. “You can ...
Our team is part of the Global Medical Affairs organization and responsible for integrating patient-focused drug development methods across Lundbeck’s development portfolio. In partnership with ...
Explore how patient experience data shapes regulatory drug decisions, enhancing the patient-focused drug development initiative for better treatment outcomes. Patient experience data are critical to ...
TUCSON, Ariz., March 10, 2026– Critical Path Institute® (C-Path) applauds the publication of a new study in the Journal of Neurology that offers critical longitudinal insights into how symptoms and ...
By integrating Folia’s innovative home-reported outcomes with our engaged health communities, we’re unlocking new possibilities for real-world evidence generation that reflects the true patient ...
Alopecia areata affects 8.3 million people globally, significantly impacting quality of life. PROMs are essential for integrating patient perspectives into drug development and evaluating treatment ...
Patient engagement has matured from aspiration to necessity as precision medicine moves from laboratory concept to bedside. Cutting-edge therapies increasingly target narrowly defined genetic or ...
Ametris (formerly ActiGraph) has launched its second Digital Endpoint Collaboration Outcome Development (DECODE) working group for the purpose of enhancing drug development for obesity. The ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results